Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
Broer, L. N., Knapen, D. G., Suurs, F. V., Moen, I., Giesen, D., Waaijer, S. J. H., Indrevoll, B., Ellingsen, C., Kristian, A., Cuthbertson, A. S., de Groot, D-J. A., Cole, P. E., de Vries, E. G. E., Hagemann, U. B. & Lub-de Hooge, M. N., 1-nov.-2022, In: The Journal of Nuclear Medicine. 63, 11, blz. 1715-1721 7 blz.Onderzoeksoutput: Article › Academic › peer review
-
Abstract CT207: A phase 1 open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a Trispecific Humabody® T-cell enhancer, in patients with PSMA+ advanced and/or metastatic solid tumors (POTENTIA)
de Bono, J. S., Arkenau, H-T., Gort, E. H., Devriese, L. L., Fontana, E., Knapen, D. G., Tiu, C., Williams, A., de Groot, D. J. A., Gunaydin, U. M., Bartlett, P., Pierce, A. J., Bland-Ward, P., Hashimoto, K. & de Vries, E. G. E., 1-jun.-2022, In: Cancer Research. 82, 12_Supplement, blz. CT207-CT207Onderzoeksoutput › Academic
-
Molecular imaging to support cancer immunotherapy
van de Donk, P. P., Oosting, S. F., Knapen, D. G., van der Wekken, A. J., Brouwers, A. H., Lub-de Hooge, M. N., de Groot, D-J. A. & de Vries, E. G. E., 3-aug.-2022, In: Journal for immunotherapy of cancer. 10, 8, 10 blz., 004949.Onderzoeksoutput: Review article › peer review
Open AccessBestand1 Citaat (Scopus)16 Downloads (Pure) -
Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1
Knapen, D. G., Cherny, N. I., Zygoura, P., Latino, N. J., Douillard, J-Y., Dafni, U., de Vries, E. G. E. & Groot, de, D. J., 6-sep.-2020, In: ESMO Open. 5, 5, 10 blz., e000681.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand5 Citaten (Scopus)91 Downloads (Pure) -
Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?
Knapen, D. G., de Groot, D. J. A., Kwee, T. C., Meijne, E. I. M., Fehrmann, R. S. N. & de Vries, E. G. E., jul.-2020, In: CANCER TREATMENT REVIEWS. 87, 4 blz., 102027.Onderzoeksoutput: Review article › peer review
Open AccessBestand2 Citaten (Scopus)78 Downloads (Pure)
Activiteiten
- 1 Professional or public presentation
-
Lower GI
Daan Knapen (Invited speaker)
28-sep.-2022Activiteit: Professional or public presentation › Professional
Knipsels
-
-
Podcast about "Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale"
06/09/2020
1 Mediabijdrage
Pers / media: Expert Comment › Professional